1.4E7 cells provide a method of producing pure insulin secreting cells when stimulated. This is an alternative to the use of primary tissue in cell transplantation therapies for type 1 diabetes.
| Inventor | Institute |
|---|---|
| Peter Flatt and Neville McClenaghan | Ulster University |
| SKU: | 161632 |
|---|---|
| Product description: | A hybrid cell line formed by the electrofusion of a primary culture of human pancreatic islets with PANC-1, a human pancreatic ductal carcinoma cell line. 1.4E7 has been shown to be tumourigenic when transplanted into a SCID mouse host. The cell line has applications in the study of pancreatic cell biology. |
| CRISPR: | No |
| Additional notes: | Patent: Flatt P & McClenaghan N (2004) Insulin producing cell-line US patent number 20040005702 (A1). Also WO0210346 (A2). |
| Parental cell line: | PANC-1 cell line |
| Model description: | Hybrid cell line formed by the electrofusion of a primary culture of human pancreatic islets with PANC-1, a human pancreatic ductal carcinoma cell line |
| Disease: | Diabetes |
| Cat. #: | 161632 |
|---|---|
| Tool sub type: | Hybrid cell line |
| Research Fields: | Disease (not cancer) |
| Organism: | Human |
| Tissue: | Pancreas |
| Model: | Transgenic |
| Morphology: | Epitheloid |
| Growth properties: | Adherent |
| Primary citation: | Lieber M et al. 1975. Int J Cancer 15: 741-747 PMID: 1140870 |
| Initial handling information: | Split sub-confluent cultures (70-80%) 1:2 to 1:6 i.e. seeding at 2-4 x 104 cells/cm� using 0.05% trypsin or trypsin/EDTA; 5% CO2; 37°C. Population doubling approx 26hrs. At confluence 105 cells/cm� can be expected. |
|---|---|
| Format: | Frozen |
| Storage conditions: | Liquid Nitrogen |
| Shipping conditions: | Dry Ice |
| Growth medium: | RPMI-1640 + 2mM Glutamine + 10% FCS |
| Temperature: | 37° C |
| Atmosphere: | 5% CO2 |
| Mycoplasma free: | Yes |
| References: |
McCluskey JT et al. 2011. J Biol Chem. Apr 22. PMID: 21515691., Guo-Parke H et al. 2012. J Endocrinol. 214(3):257-65. PMID: 22685334 |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.